Epigenetics Market Size - Global Industry, Share, Analysis, Trends and Forecast 2024 - 2032

CHAPTER 1. Industry Overview of Epigenetics Market

1.1. Definition and Scope

1.1.1. Definition of Epigenetics

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Epigenetics Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Epigenetics Market By Product

1.2.3. Epigenetics Market By Technology

1.2.4. Epigenetics Market By Application

1.2.5. Epigenetics Market By End-Use

1.2.6. Epigenetics Market By Region

 

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

 

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Epigenetics Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Epigenetics Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2023

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

 

CHAPTER 4. Epigenetics Market By Product

4.1. Introduction

4.2. Epigenetics Revenue By Product

4.2.1. Epigenetics Revenue (USD Million) and Forecast, By Product, 2020-2032

4.2.2. Reagents

4.2.2.1. Reagents Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3. Kits

4.2.3.1. Kits Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.2. Whole Genomic Amplification kit

4.2.3.2.1. Whole Genomic Amplification kit Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.3. ChIP sequencing kit

4.2.3.3.1. ChIP sequencing kit Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.4. Bisulfite Conversion kit

4.2.3.4.1. Bisulfite Conversion kit Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.5. RNA sequencing kit

4.2.3.5.1. RNA sequencing kit Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.3.6. Others

4.2.3.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.4. Enzymes

4.2.4.1. Enzymes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.5. Instruments

4.2.5.1. Instruments Market Revenue (USD Million) and Growth Rate (%), 2020-2032

4.2.6. Services

4.2.6.1. Services Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 5. Epigenetics Market By Technology

5.1. Introduction

5.2. Epigenetics Revenue By Technology

5.2.1. Epigenetics Revenue (USD Million) and Forecast, By Technology, 2020-2032

5.2.2. Histone Methylation

5.2.2.1. Histone Methylation Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. DNA Methylation

5.2.3.1. DNA Methylation Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Large Non-Coding RNA

5.2.4.1. Large Non-Coding RNA Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Histone Acetylation

5.2.5.1. Histone Acetylation Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.6. Chromatin Structures

5.2.6.1. Chromatin Structures Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.7. MicroRNA Modification

5.2.7.1. MicroRNA Modification Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 6. Epigenetics Market By Application

6.1. Introduction

6.2. Epigenetics Revenue By Application

6.2.1. Epigenetics Revenue (USD Million) and Forecast, By Application, 2020-2032

6.2.2. Oncology

6.2.2.1. Oncology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.2. Solid Tumors

6.2.2.2.1. Solid Tumors Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.2.3. Liquid Tumors

6.2.2.3.1. Liquid Tumors Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Non-Oncology

6.2.3.1. Non–Oncology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.2. Inflammatory Diseases

6.2.3.2.1. Inflammatory Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.3. Metabolic Diseases

6.2.3.3.1. Metabolic Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.4. Infectious Diseases

6.2.3.4.1. Infectious Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.5. Cardiovascular Diseases

6.2.3.5.1. Cardiovascular Diseases Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3.6. Others

6.2.3.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 7. Epigenetics Market By End-Use

7.1. Introduction

7.2. Epigenetics Revenue By End-Use

7.2.1. Epigenetics Revenue (USD Million) and Forecast, By End-Use, 2020-2032

7.2.2. Clinical Research

7.2.2.1. Clinical Research Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Academic Research

7.2.3.1. Academic Research Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Pharmaceutical & Biotechnology Companies

7.2.4.1. Pharmaceutical & Biotechnology Companies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.5. Hospitals & Clinics

7.2.5.1. Hospitals & Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.6. Others

7.2.6.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

 

CHAPTER 8. North America Epigenetics Market By Country 

8.1. North America Epigenetics Market Overview

8.2. U.S.

8.2.1. U.S. Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

8.2.2. U.S. Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

8.2.3. U.S. Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

8.2.4. U.S. Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

8.3. Canada

8.3.1. Canada Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

8.3.2. Canada Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

8.3.3. Canada Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

8.3.4. Canada Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

8.4. North America PEST Analysis

 

CHAPTER 9. Europe Epigenetics Market By Country

9.1. Europe Epigenetics Market Overview

9.2. U.K.

9.2.1. U.K. Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

9.2.2. U.K. Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

9.2.3. U.K. Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

9.2.4. U.K. Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.3. Germany

9.3.1. Germany Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

9.3.2. Germany Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

9.3.3. Germany Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

9.3.4. Germany Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.4. France

9.4.1. France Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

9.4.2. France Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

9.4.3. France Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

9.4.4. France Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.5. Spain

9.5.1. Spain Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

9.5.2. Spain Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

9.5.3. Spain Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

9.5.4. Spain Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

9.6.2. Rest of Europe Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

9.6.3. Rest of Europe Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

9.6.4. Rest of Europe Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.7. Europe PEST Analysis

 

CHAPTER 10. Asia Pacific Epigenetics Market By Country

10.1. Asia Pacific Epigenetics Market Overview

10.2. China

10.2.1. China Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

10.2.2. China Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

10.2.3. China Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

10.2.4. China Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.3. Japan

10.3.1. Japan Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

10.3.2. Japan Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

10.3.3. Japan Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

10.3.4. Japan Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.4. India

10.4.1. India Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

10.4.2. India Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

10.4.3. India Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

10.4.4. India Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.5. Australia

10.5.1. Australia Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

10.5.2. Australia Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

10.5.3. Australia Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

10.5.4. Australia Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.6. South Korea

10.6.1. South Korea Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

10.6.2. South Korea Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

10.6.3. South Korea Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

10.6.4. South Korea Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

10.7.2. Rest of Asia-Pacific Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

10.7.3. Rest of Asia-Pacific Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

10.7.4. Rest of Asia-Pacific Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.8. Asia Pacific PEST Analysis

 

CHAPTER 11. Latin America Epigenetics Market By Country

11.1. Latin America Epigenetics Market Overview

11.2. Brazil

11.2.1. Brazil Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

11.2.2. Brazil Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

11.2.3. Brazil Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

11.2.4. Brazil Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.3. Mexico

11.3.1. Mexico Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

11.3.2. Mexico Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

11.3.3. Mexico Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

11.3.4. Mexico Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

11.4.2. Rest of Latin America Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

11.4.3. Rest of Latin America Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

11.4.4. Rest of Latin America Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.5. Latin America PEST Analysis

 

CHAPTER 12. Middle East & Africa Epigenetics Market By Country 

12.1. Middle East & Africa Epigenetics Market Overview

12.2. GCC

12.2.1. GCC Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

12.2.2. GCC Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

12.2.3. GCC Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

12.2.4. GCC Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.3. South Africa

12.3.1. South Africa Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

12.3.2. South Africa Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

12.3.3. South Africa Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

12.3.4. South Africa Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Epigenetics Revenue (USD Million) and Forecast By Technology, 2020-2032

12.4.2. Rest of Middle East & Africa Epigenetics Revenue (USD Million) and Forecast By Product, 2020-2032

12.4.3. Rest of Middle East & Africa Epigenetics Revenue (USD Million) and Forecast By Application, 2020-2032

12.4.4. Rest of Middle East & Africa Epigenetics Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.5. Middle East & Africa PEST Analysis

 

CHAPTER 13. Player Analysis Of Epigenetics Market

13.1. Epigenetics Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Epigenetics Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

 

CHAPTER 14. Company Profile

14.1. Bayer AG

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2023

14.1.3.2. Bayer AG 2023 Epigenetics Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Pfizer Inc.

14.3. Incyte Corporation

14.4. Novartis AG

14.5. AbbVie Inc.

14.6. Johnson & Johnson

14.7. BeiGene Ltd.

14.8. Epizyme, Inc.

14.9. AstraZeneca PLC

14.10. Merck & Co., Inc.

14.11. GlaxoSmithKline PLC

14.12. Bristol Myers Squibb Company